Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-02-13
2009-12-08
Saeed, Kamal A (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S421000, C548S484000
Reexamination Certificate
active
07629376
ABSTRACT:
The present invention discloses and claims compounds of formula (I) and formula (II)as inhibitors of human casein kinase Iε, and methods of using the compounds of formula (I) and formula (II) for treating central nervous system diseases and disorders including mood disorders and sleep disorders. The R-group substituents are defined herein and pharmaceutical compositions comprising compounds of formula (I) or formula (II) are also disclosed and claimed.
REFERENCES:
patent: WO 94/14851 (1994-02-01), None
patent: WO 2005/061498 (2005-07-01), None
Ning, K., et. al., Circadian Regulation of GABAA Receptor Function by CKI-Epsilon-CKI-delta in the rat Suprachiasmatic Nuclei, Nature Neuroscience, Nature American, vol. 7, No. 5, (2004).
Ding Fa-Xiang
Metz, Jr. William Arthur
Aventis Pharmaceuticals Inc.
Bell Craig M.
Martin Lawrence L.
Nolan Jason M
Saeed Kamal A
LandOfFree
3-substituted-5- and 6-aminoalkyl indole-2-carboxylic acid... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-substituted-5- and 6-aminoalkyl indole-2-carboxylic acid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-substituted-5- and 6-aminoalkyl indole-2-carboxylic acid... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4092855